InsidersTradesSigma
Track the PRO MEDICUS LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the authority of ASX. Market capitalisation: €18.7bn. The latest transaction was filed on 7 September 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. Every trade is accessible without an account.
Analysts rate PRO MEDICUS LIMITED Buy (bullish), based on 15 analysts. Average price target: A$202.47.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
PRO MEDICUS LIMITED 是一家澳大利亚公司，专注于医学影像软件解决方案。它提供工具以提高医疗保健服务的效率和质量。